Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of Pieris Pharmaceuticals stock opened at $0.19 on Friday. Pieris Pharmaceuticals has a twelve month low of $0.14 and a […]
More Stories
Cousins Properties (NYSE:CUZ) Stock Rating Lowered by StockNews.com
Cousins Properties (NYSE:CUZ – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a...
Mohawk Industries (NYSE:MHK) Upgraded at StockNews.com
Mohawk Industries (NYSE:MHK – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a...
StockNews.com Upgrades Viavi Solutions (NASDAQ:VIAV) to “Buy”
Viavi Solutions (NASDAQ:VIAV – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy”...
Wishbone Gold (LON:WSBN) Stock Price Down 4.2% – Should You Sell?
Shares of Wishbone Gold Plc (LON:WSBN – Get Free Report) dropped 4.2% during trading on Thursday . The company traded...
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Increased to Strong-Buy at StockNews.com
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by stock analysts at StockNews.com from a “buy” rating to...
Shoe Zone (LON:SHOE) Stock Passes Below 50-Day Moving Average – Here’s What Happened
Shares of Shoe Zone plc (LON:SHOE – Get Free Report) crossed below its fifty day moving average during trading on...